HLNE:NASDAQHamilton Lane Incorporated Analysis

Hamilton Lane (HLNE) is trading around $88.9, which sits above its DCF‑derived fair value of $58.4 but still well below the analyst median target of $123, implying a sizable upside potential. The stock trades at a forward P/E of ~12x versus an industry average of 18x, and its trailing P/E of 15x is modest given a 32% ROE and robust operating margins above 40%, suggesting a blend of value and growth characteristics. Dividend sustainability looks solid with a 2.7% yield, a payout ratio under 40%, and ample free cash flow to cover distributions. Technicals are supportive: the 20‑day SMA (84.1) is below the current price, the MACD histogram is positive and labeled bullish, and the RSI at 62 indicates momentum without being overbought. Recent news of an expanded partnership with iCapital adds a catalyst that could broaden distribution of HLNE’s strategies to wealth managers worldwide.
Overall, the stock presents a moderate risk profile—beta slightly above 1, 30‑day volatility above 40%, but a market cap near $6 bn and stable volume mitigate liquidity concerns. The combination of attractive valuation metrics, a durable dividend, and positive momentum supports a short‑ to medium‑term buying case, while the long‑run outlook remains contingent on the firm’s ability to sustain growth in the competitive alternative‑asset space.